AWM — Airway Medix SA Income Statement
0.000.00%
- PLN19.98m
- PLN39.76m
- PLN0.01m
Annual income statement for Airway Medix SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.257 | 0 | 0.095 | 0.012 | 0.012 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | -0.006 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.47 | 8.77 | 36.3 | 2.66 | 6.4 |
Operating Profit | -2.21 | -8.77 | -36.2 | -2.65 | -6.39 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.99 | -9.76 | -37.4 | -3.28 | -11.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.37 | -7.44 | -37.9 | -3.28 | -11.7 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.37 | -7.44 | -37.9 | -3.28 | -11.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.37 | -7.44 | -37.9 | -3.28 | -11.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.041 | -0.127 | -0.279 | -0.054 | -0.159 |
Dividends per Share |